Cns Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 61.00 K | $145.79 K | 24.93% | 9.02% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 45.83 K | $109.99 K | 0.00% | 6.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 23.19 K | $55.65 K | 100.00% | 3.43% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 13.52 K | $32.32 K | 0.00% | 2.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.31 K | $3.13 K | 100.00% | 0.19% |
| UBS GROUP AG | 05/05/2026 | 729 | $1.74 K | 19.31% | 0.11% |
| BARRETT & COMPANY, INC. | 05/04/2026 | 8 | $19 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 05/15/2026 | 3 | $8 | 0.00% | 0.00% |
| DANSKE BANK A/S | 05/12/2026 | 1 | $2 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 1 | $2 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 1 | $2 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cns Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 15 institutional investors and hedge funds held shares of Cns Pharmaceuticals Inc. The most heavily invested institutionals were:
Stonepine Capital Management, LLC: 61,000
Ikarian Capital, LLC: 45,830
GEODE CAPITAL MANAGEMENT, LLC: 23,189
BOOTHBAY FUND MANAGEMENT, LLC: 13,524
Tower Research Capital LLC (TRC): 1,310
UBS Group AG: 729
21.53% of Cns Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 145.73 K shares in the last 24 months. This purchase volume represents approximately $443.01 K in transactions.